Tianzhen Wang

Prof. Tianzhen Wang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
CYChao Yang
Chao Yang
DWDi Wu
Di Wu
LGLin Gao
Lin Gao
XLXi Liu
Xi Liu
YJYinji Jin
Yinji Jin
Xiaobo LiXiaobo Li
Xiaobo Li
Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives

30 June 2015 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
TWTianzhen Wang
Tianzhen Wang
GWGuangyu Wang
Guangyu Wang
DHDapeng Hao
Dapeng Hao
XLXi Liu
Xi Liu
DWDong Wang
Dong Wang
Xiaobo LiXiaobo Li
Xiaobo Li
RNA binding proteins (RBPs) and microRNAs (miRNAs) are two of the most important post-transcriptional regulators of gene expression, and their aberrant expression contributes to the development of human malignancies. Let-7, one of the most well-known tumor suppressors, is frequently down-regulated in a variety of human cancers. The RBP LIN28A/LIN28B, a direct target of the let-7 family of miRNAs, is an inhibitor of let-7 biogenesis and is frequently up-regulated in cancers. Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors is reportedly involved in cancer development, contributing to cellular proliferation, cell death resistance, angiogenesis, metastasis, metabolism reprogramming, tumor-associated inflammation, genome instability, acquiring immortality and evading immune destruction. In this review, we summarized the mechanisms of LIN28A/LIN28B and let-7 loop aberrant regulation in human cancer and discussed the roles and potential mechanisms of the LIN28A/LIN28B and let-7 loop in regulating the hallmarks of cancer. The crosstalk between LIN28A/LIN28B and let-7 loop and certain oncogenes (such as MYC, RAS, PI3K/AKT, NF-κB and β-catenin) in regulating hallmarks of cancer has also been discussed.

1 March 2017 in Translational Research
Verified
Journal Article
Closed access
MWMingjiao Weng
Mingjiao Weng
DWDi Wu
Di Wu
CYChao Yang
Chao Yang
HPHaisheng Peng
Haisheng Peng
GWGuangyu Wang
Guangyu Wang
Xiaobo LiXiaobo Li
Xiaobo Li

4 November 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
ZLZhigang Li
Zhigang Li
QGQingyu Guo
Qingyu Guo
JZJiaxin Zhang
Jiaxin Zhang
ZFZitong Fu
Zitong Fu
YWYifei Wang
Yifei Wang
JTJing Tang
Jing Tang
The RNA-binding motif (RBM) proteins are a class of RNA-binding proteins named, containing RNA-recognition motifs (RRMs), RNA-binding domains, and ribonucleoprotein motifs. RBM proteins are involved in RNA metabolism, including splicing, transport, translation, and stability. Many studies have found that aberrant expression and dysregulated function of RBM proteins family members are closely related to the occurrence and development of cancers. This review summarizes the role of RBM proteins family genes in cancers, including their roles in cancer occurrence and cell proliferation, migration, and apoptosis. It is essential to understand the mechanisms of these proteins in tumorigenesis and development, and to identify new therapeutic targets and prognostic markers.

29 April 2019 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
XZXiao Zhang
Xiao Zhang
YFYukuan Feng
Yukuan Feng
XLXi Liu
Xi Liu
JMJianhui Ma
Jianhui Ma
YLYafei Li
Yafei Li
Xiaobo LiXiaobo Li
Xiaobo Li

9 November 2020 in Carcinogenesis
Verified
Journal Article
Closed access
PDF file
JTJing Tang
Jing Tang
LYLirui Yang
Lirui Yang
YLYafei Li
Yafei Li
XNXuelian Ning
Xuelian Ning
ACAnita Chaulagain
Anita Chaulagain
DWDong Wang
Dong Wang
Colorectal cancer (CRC) is one of the most common malignant tumours, and its morbidity and mortality rates are relatively high. However, the aetiology and pathogenesis of CRC have not been clearly elucidated to date. AT-rich interaction domain 3A (ARID3A) is a member of the ARID3 family and a transcription factor that can bind to specific DNA sites to regulate gene expression. It was reported that ARID3A is involved in various biological processes and may be related to carcinogenesis. In this study, by assessing the mRNA level of ARID3A in TCGA database, we found that ARID3A expression increased in CRC tissues, and proposed that ARID3A could act as a tumour-promoting factor in the development of CRC. To verify this hypothesis, we used cell proliferation, migration and invasion assays to assess the effect of ARID3A on CRC cells. We revealed that ARID3A overexpression enhanced tumour cell proliferation, migration and invasion. ARID3A could target Aurora kinase A (AURKA) to facilitate the malignant phenotype of CRC cells, and patients with a higher ratio of AURKA and ARID3A had a better overall survival. Conclusively, this study showed that ARID3A targeted AURKA to facilitate the development of CRC. The ratio of ARID3A and AURKA could be used as a potential biomarker to predict prognosis, providing a new strategy for the diagnosis and prognosis of CRC.